Patents by Inventor John C. Hedenstrom

John C. Hedenstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10071156
    Abstract: Aqueous gel formulations, including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, pyrazolopyridine amines, pyrazoloquinoline amines, tetrahydropyrazoloquinoline amines, pyrazolonaphthyridine amines, tetrahydropyrazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. Methods of use and kits are also provided.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: September 11, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: David Q. Ma, Christopher S. Perman, Raymond D. Skwierczynski, John C. Hedenstrom
  • Publication number: 20160101173
    Abstract: Aqueous gel formulations, including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, pyrazolopyridine amines, pyrazoloquinoline amines, tetrahydropyrazoloquinoline amines, pyrazolonaphthyridine amines, tetrahydropyrazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. Methods of use and kits are also provided.
    Type: Application
    Filed: December 16, 2015
    Publication date: April 14, 2016
    Inventors: DAVID Q. MA, CHRISTOPHER S. PERMAN, RAYMOND D. SKWIERCZYNSKI, JOHN C. HEDENSTROM
  • Patent number: 9248127
    Abstract: Aqueous gel formulations, including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, pyrazolopyridine amines, pyrazoloquinoline amines, tetrahydropyrazoloquinoline amines, pyrazolonaphthyridine amines, tetrahydropyrazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. Methods of use and kits are also provided.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: February 2, 2016
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Christopher S. Perman, Raymond D. Skwierczynski, David Q. Ma, John C. Hedenstrom
  • Publication number: 20090163532
    Abstract: Aqueous gel formulations, including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, pyrazolopyridine amines, pyrazoloquinoline amines, tetrahydropyrazoloquinoline amines, pyrazolonaphthyridine amines, tetrahydropyrazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. Methods of use and kits are also provided.
    Type: Application
    Filed: February 3, 2006
    Publication date: June 25, 2009
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: Christopher S. Perman, Raymond D. Skwierczynski, David Q. Ma, John C. Hedenstrom
  • Publication number: 20080207675
    Abstract: Pharmaceutical formulations in an aqueous gel formulation including 1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine are provided. Methods of use and kits are also provided.
    Type: Application
    Filed: February 3, 2006
    Publication date: August 28, 2008
    Inventors: David Q. Ma, Christopher S. Perman, Raymond D. Skwierczynski, John C. Hedenstrom
  • Patent number: 6706728
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: March 16, 2004
    Assignee: 3M Innovative Properties Company
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter, Jr.
  • Publication number: 20030045543
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Application
    Filed: September 10, 2002
    Publication date: March 6, 2003
    Applicant: 3M Innovative Properties Company
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter
  • Publication number: 20020058674
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Application
    Filed: June 22, 2001
    Publication date: May 16, 2002
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter
  • Patent number: 6132760
    Abstract: A transdermal delivery device including an adhesive layer that contains a therapeutically effective amount of testosterone and a delivery enhancing adjuvant comprising a terpene.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: October 17, 2000
    Assignee: 3M Innovative Properties Company
    Inventors: John C. Hedenstrom, Michael L. Husberg, Shari L. Wilking, Matthew T. Scholz
  • Patent number: 6019997
    Abstract: Hydroalcoholic compositions useful for the enhancement of the transdermal delivery of a pharmaceutical agent, methods of preparation, transdermal delivery systems, and methods of delivering the pharmaceutical agent are provided. The composition includes a lower alcohol and water in a weight ratio of at least about 20:80, a pharmaceutical agent, and an emulsifier system.
    Type: Grant
    Filed: January 9, 1997
    Date of Patent: February 1, 2000
    Assignee: Minnesota Mining and Manufacturing
    Inventors: Matthew T. Scholz, Robert A. Asmus, John C. Hedenstrom